Global information about the Novavax COVID-19 Vaccine (recombinant, adjuvanted)

The approval status of the Novavax COVID-19 Vaccine (recombinant, adjuvanted) (also known as NVX-CoV2373) varies worldwide. In countries where the vaccine has not been approved by the relevant regulatory authority or regulatory process, you will not find information about it on this site. This site will be updated as more information becomes available.

Please answer the questions below.